Search results
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
Investor's Business Daily· 2 years agoMerck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris...
Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris
Zacks via Yahoo Finance· 2 years agoMerck (MRK) gets a favorable ruling from a district court of West Virginia in two patents related to...
The secret to breaking down the high price of prescription drugs
WPXI via Yahoo News· 2 years agoAn investigation has uncovered the secret to many newer name-brand medications. Some of these...
Merck wins ruling upholding diabetes-treatment patent at U.S. appeals court
Reuters via Yahoo Finance· 2 years agoA Merck Sharp & Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan ...
Pharma CEOs grilled by senators over sky-high drug prices
NBC News via Yahoo News· 4 months agoWASHINGTON — Lawmakers sharply criticized the CEOs of three major drugmakers during a Senate...
Medicare's drug pricing list didn't impact company stocks — here's why
Yahoo Finance· 9 months agoInvestor sentiment was indifferent towards the historic announcement Tuesday by the Biden...
Important News Update: How To Save on All of Your Prescriptions
First for Women via Yahoo News· 9 months agoOn August 29, 2023, the Biden administration unveiled the first 10 drugs that will be subjects of...
Medicare recipients say new drug price negotiations will save them thousands
ABC News via Yahoo News· 9 months agoEvery month, Dawn LaGuerre has to decide which bills she's going to pay or if she needs to cut back...
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
Motley Fool· 9 months agoAbout a year ago, President Joe Biden signed the Inflation Reduction Act into law. Among the many...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 9 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...